Drug Discovery News
-
Takeda Gemini II trial shows positive results
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 14 May, 2012
Singapore: Positive results were reported from Takeda Pharmaceutical's international, randomized, placebo-controlled, ...Read more
-
IOF, Fonterra grants $43K to Indonesian for bone R&D
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 25 Jul, 2013
Singapore: Global organization, International Osteoporosis Foundation (IOF), and New Zealand dairy firm, Fonterra have c...Read more
-
Vanda Pharma withdraws application for Fanaptum
Drug Discovery | Regulatory | By BioSpectrum Bureau | 0 Comment | 15 Mar, 2013
Singapore: Vanda Pharmaceuticals has withdrawn its application from European Medicines Agency for a centralized marketin...Read more
-
AbbVie invests $320 mn in bilogics manufacturing in Singapore
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2014
Singapore: Research based pharmaceutical company, AbbVie, has made investment of around USD320 million in Singapore to s...Read more
-
Prana Alzheimer's trial shows +ve results
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 08 Apr, 2013
Singapore: Prana Biotechnology reported on the progress of its lead development asset PBT2, which is in phase II trials ...Read more
-
Astellas to do interim analysis of cancer trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 03 Apr, 2013
Singapore: Medivation and Astellas Pharma have established an updated interim analysis plan for the Prevail trial, a glo...Read more
-
Novartis acquires cancer firm CoStim
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 18 Feb, 2014
Singapore: Global pharmaceutical firm, Novartis, has acquired CoStim Pharmaceuticals, a privately held biotechnology com...Read more
-
Cytos reveals trial data allergic asthma immune modulator
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 09 Sep, 2013
Singapore: Cytos Biotechnology revealed additional results of the phase IIa clinical trial with CYT003, a first-in-class...Read more
-
Prism to start PRI-724 trials to treat fibrosis
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 14 Jun, 2013
Singapore: Prism Pharma, a drug discovery company focused on developing small molecule technologies that modulate protei...Read more
-
Boehringer, Eli Lilly reveal post-hoc results for linagliptin
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 11 Jun, 2012
Singapore: Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Company revealed results from a post-hoc analysis, whi...Read more
-
Bayer recognizes innovation by Korean start-up
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 30 Aug, 2016
Singapore: Vital Smith, a Korean startup which focuses on developing innovative technology for diagnostics devices is r...Read more
-
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 09 Aug, 2012
Singapore: Green Cross, a leading biotechnology company in South Korea, has signed a memorandum of understanding (MOU) ...Read more
-
Chugai gets Japanese nod cancer drug Kadcyla
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 23 Sep, 2013
Singapore: The Japanese Ministry of Health, Labour and Welfare has approved Oncology specializing pharmaceutical firm Ch...Read more
-
Nexavar seeks marketing authorization in Japan
Drug Discovery | Regulatory | By BioSpectrum Bureau | 0 Comment | 01 Oct, 2013
Singapore: Bayer HealthCare has submitted an additional application for marketing authorization to the Ministry of Healt...Read more
-
Starpharma to receive $6 mn for overseas R&D
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 23 Nov, 2012
Singapore: Australia-based Starpharma is eligible to receive approximately $6 million cash in R&D tax incentives for...Read more
-
Thermo Fisher Scientific celebrates 20th year in Singapore
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 30 Aug, 2016
Singapore: Thermo Fisher Scientific has completed 20th year of its operation in Singapore. The company celebrated the mi...Read more
-
FDA to review Vanda blindness drug Tasimelteon
Drug Discovery | Regulatory | By BioSpectrum Bureau | 0 Comment | 31 Jul, 2013
Singapore: The US FDA has granted priority review classification to Vanda's New Drug Application (NDA) for tasimelteon, ...Read more
-
Novartis' Jakavi improves myelofibrosis
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 11 Dec, 2012
Singapore: Phase III studies by Novartis has demonstrated that Jakavi (INC424, ruxolitinib) treatment resulted in sustai...Read more
